These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Data revisited. Yannuzzi LA Arch Ophthalmol; 1994 Apr; 112(4):462-4. PubMed ID: 7512331 [No Abstract] [Full Text] [Related]
4. Treatment options In subfoveal choroidal neovascularization secondary to age-related macular degeneration. Shiraga F; Takasu I; Shiragami C Semin Ophthalmol; 1998 Mar; 13(1):31-9. PubMed ID: 9567010 [TBL] [Abstract][Full Text] [Related]
5. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335 [TBL] [Abstract][Full Text] [Related]
6. The peril of the pilot study. Ferris FL; Murphy RP Arch Ophthalmol; 1996 Dec; 114(12):1506-7. PubMed ID: 8953984 [No Abstract] [Full Text] [Related]
7. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group. Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004 [TBL] [Abstract][Full Text] [Related]
8. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976 [TBL] [Abstract][Full Text] [Related]
12. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group. Arch Ophthalmol; 1994 Apr; 112(4):480-8. PubMed ID: 7512334 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiation therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Holz FG; Engenhart R; Bellmann C; Debus J; Völcker HE Front Radiat Ther Oncol; 1997; 30():238-46. PubMed ID: 9205906 [No Abstract] [Full Text] [Related]
14. Submacular surgery for choroidal neovascularisation. Kaplan H Br J Ophthalmol; 1996 Feb; 80(2):101. PubMed ID: 8814737 [No Abstract] [Full Text] [Related]
15. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725 [TBL] [Abstract][Full Text] [Related]
18. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol; 1991 Sep; 109(9):1232-41. PubMed ID: 1718251 [TBL] [Abstract][Full Text] [Related]
19. Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Sharma S Can J Ophthalmol; 2001 Feb; 36(1):7-10. PubMed ID: 11227391 [No Abstract] [Full Text] [Related]